Mark Moran

1.3k total citations
19 papers, 1.0k citations indexed

About

Mark Moran is a scholar working on Physiology, Pharmacology and Molecular Biology. According to data from OpenAlex, Mark Moran has authored 19 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Physiology, 8 papers in Pharmacology and 5 papers in Molecular Biology. Recurrent topics in Mark Moran's work include Alzheimer's disease research and treatments (11 papers), Cholinesterase and Neurodegenerative Diseases (8 papers) and Computational Drug Discovery Methods (5 papers). Mark Moran is often cited by papers focused on Alzheimer's disease research and treatments (11 papers), Cholinesterase and Neurodegenerative Diseases (8 papers) and Computational Drug Discovery Methods (5 papers). Mark Moran collaborates with scholars based in Spain, United States and Chile. Mark Moran's co-authors include Pilar Gómez‐Ramos, Elliott J. Mufson, M.‐Marsel Mesulam, M‐Marsel Mesulam, Marsel Mesulam, Changiz Geula, Jesús Ávila, Filip Lim, José J. Lucas and Félix Hernández and has published in prestigious journals such as The Journal of Comparative Neurology, Annals of Neurology and Brain Research.

In The Last Decade

Mark Moran

17 papers receiving 1.0k citations

Peers

Mark Moran

PHYSI

PHARM

CMN

Chuang-Kuo Wu United States

Luis Pennanen Switzerland

Evgeny A. Sametsky United States

Arielle Ungerer France

Chantal Mathis France

Rimante Minkeviciene Finland

Benedikt Zott Germany

Rachel D. Penrod United States

Evelin L. Schaeffer Brazil

A Tennstedt Germany

Chuang-Kuo Wu United States

Mark Moran

748 ×1.4

PHYSI

255 ×0.7

PHARM

365 ×1.3

311 ×1.2

CMN

162 ×0.6

Citations per year, relative to Mark Moran Mark Moran (= 1×) peers Chuang-Kuo Wu

Countries citing papers authored by Mark Moran

Since Specialization

Citations

This map shows the geographic impact of Mark Moran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Moran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Moran more than expected).

Fields of papers citing papers by Mark Moran

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Moran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Moran. The network helps show where Mark Moran may publish in the future.

Co-authorship network of co-authors of Mark Moran

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Moran. A scholar is included among the top collaborators of Mark Moran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Moran. Mark Moran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Moran, Mark. (2017). AMA Code of Medical Ethics Gets Long-Awaited Update. Psychiatric News. 52(5). 1–1. 1 indexed citations

Moran, Mark. (2016). CMS Finalizes Code for Collaborative Care. Psychiatric News. 51(23). 1–1. 2 indexed citations

Moran, Mark. (2012). Often-Used CPT Codes Are Changing. Psychiatric News. 47(11). 13a–13a.

Velásquez, Zahady D., Mar Pérez, Mark Moran, et al.. (2010). Ultrastructural localization of fructose‐1,6‐bisphosphatase in mouse brain. Microscopy Research and Technique. 74(4). 329–336. 4 indexed citations

Engel, Tobías, Paloma Goñi‐Oliver, Pilar Gómez‐Ramos, et al.. (2008). Hippocampal neuronal subpopulations are differentially affected in double transgenic mice overexpressing frontotemporal dementia and parkinsonism linked to chromosome 17 tau and glycogen synthase kinase-3β. Neuroscience. 157(4). 772–780. 7 indexed citations

Gómez‐Ramos, Pilar & Mark Moran. (2007). Ultrastructural Localization of Intraneuronal Aβ-Peptide in Alzheimer Disease Brains. Journal of Alzheimer s Disease. 11(1). 53–59. 65 indexed citations

Ribé, Elena M., Mar Pérez, Berta Puig, et al.. (2005). Accelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP/tau transgenic mice. Neurobiology of Disease. 20(3). 814–822. 128 indexed citations

Moran, Mark. (2005). Part D Plans May Be Startled By Drug Costs for Dual Eligibles. Psychiatric News. 40(18). 18–35. 1 indexed citations

Pérez, Mar, Elena M. Ribé, Alicia Rubio, et al.. (2004). Characterization of a double (amyloid precursor protein-tau) transgenic: Tau phosphorylation and aggregation. Neuroscience. 130(2). 339–347. 61 indexed citations

10.

Moran, Mark, et al.. (2001). Ubiquitinated granular structures and initial neurofibrillary changes in the human brain. Journal of the Neurological Sciences. 192(1-2). 27–34. 13 indexed citations

11.

Lim, Filip, Félix Hernández, José J. Lucas, et al.. (2001). FTDP-17 Mutations in tau Transgenic Mice Provoke Lysosomal Abnormalities and Tau Filaments in Forebrain. Molecular and Cellular Neuroscience. 18(6). 702–714. 158 indexed citations

12.

Gómez‐Ramos, Pilar, Elliott J. Mufson, & Mark Moran. (2001). Apolipoprotein E immunoreactivity in neurons and neurofibrillary degeneration of aged non‐demented and alzheimer's disease patients. Microscopy Research and Technique. 55(1). 48–58. 9 indexed citations

13.

Gómez‐Ramos, Pilar & Mark Moran. (1997). Ultrastructural localization of butyrylcholinesterase in senile plaques in the brains of aged and Alzheimer disease patients. Molecular and Chemical Neuropathology. 30(3). 161–173. 43 indexed citations

14.

Moran, Mark & Pilar Gómez‐Ramos. (1992). Cholinesterase histochemistry in the human brain: effect of various fixation and storage conditions. Journal of Neuroscience Methods. 43(1). 49–54. 12 indexed citations

15.

Gómez‐Ramos, Pilar, Elliott J. Mufson, & Mark Moran. (1992). Ultrastructural localization of acetylcholinesterase in neurofibrillary tangles, neuropil threads and senile plaques in aged and Alzheimer's brain. Brain Research. 569(2). 229–237. 34 indexed citations

16.

Moran, Mark & Fernando Reinoso‐Suárez. (1988). Topographical organization of the thalamic afferent connections to the motor cortex in the cat. The Journal of Comparative Neurology. 270(1). 64–85. 21 indexed citations

17.

Mesulam, M‐Marsel & Mark Moran. (1987). Cholinesterases within neurofibrillary tangles related to age and Alzheimer's disease. Annals of Neurology. 22(2). 223–228. 108 indexed citations

18.

Mesulam, Marsel, Changiz Geula, & Mark Moran. (1987). Anatomy of cholinesterase inhibition in Alzheimer's disease: Effect of physostigmine and tetrahydroaminoacridine on plaques and tangles. Annals of Neurology. 22(6). 683–691. 150 indexed citations

19.

Moran, Mark, Elliott J. Mufson, & M.‐Marsel Mesulam. (1987). Neural inputs into the temporopolar cortex of the rhesus monkey. The Journal of Comparative Neurology. 256(1). 88–103. 219 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact